$SCPX
Scorpius Holdings, Inc. Stock $scpx

$scpx Overview Financials Valuation SEC Filings Company Website

2015 Q1 Form 10-K Financial Statement

#000155335015000277 Filed on March 27, 2015

Income Statement

Concept	2015 Q1	2014	2013 Q4
Revenue	$9.126K	$40.57K	$0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin	$1.310M	$4.113M	$990.0K
YoY Change	29.7%	60.34%	160.53%
% of Gross Profit
Research & Development	$503.6K	$2.861M	$620.0K
YoY Change	-5.64%	4.51%	100.0%
% of Gross Profit
Depreciation & Amortization	$25.61K	$66.90K	$10.00K
YoY Change	1080.28%	953.8%
% of Gross Profit
Operating Expenses	$3.982M	$12.19M	$2.250M
YoY Change	66.28%	85.64%	204.05%
Operating Profit	-$3.982M	-$12.19M
YoY Change	66.28%	85.64%
Interest Expense	$50.39K	$73.35K	$30.00K
YoY Change		-7.29%	-250.0%
% of Operating Profit
Other Income/Expense, Net	-$44.69K	-$56.28K	$100.0K
YoY Change	59.12%	24.46%	-1100.0%
Pretax Income	-$4.030M	-$12.24M	-$2.120M
YoY Change	66.53%	85.17%	175.32%
Income Tax			$0.00
% Of Pretax Income
Net Earnings	-$3.909M	-$11.79M	-$2.060M
YoY Change	67.73%	29.93%	174.67%
Net Earnings / Revenue	-42835.83%	-29057.97%
Basic Earnings Per Share
Diluted Earnings Per Share	-$39.10	-$131.00	-$22.88
COMMON SHARES
Basic Shares Outstanding	8.394M shares
Diluted Shares Outstanding

Balance Sheet

Concept	2015 Q1	2014	2013 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments	$21.10M	$14.40M	$21.90M
YoY Change	8.76%	-34.25%
Cash & Equivalents	$10.27M	$3.700M	$4.567M
Short-Term Investments	$10.80M	$10.70M	$17.30M
Other Short-Term Assets	$1.100M	$900.0K	$1.100M
YoY Change	22.22%	-18.18%	1000.0%
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets	$22.15M	$15.30M	$22.93M
YoY Change	8.94%	-33.48%	31296.13%
LONG-TERM ASSETS
Property, Plant & Equipment	$428.2K	$400.0K	$53.75K
YoY Change	654.7%	300.0%	398.54%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$251.5K	$100.0K	$35.52K
YoY Change	2279.3%		-44.3%
Total Long-Term Assets	$679.7K	$600.0K	$89.27K
YoY Change	909.87%		40.0%
TOTAL ASSETS
Total Short-Term Assets	$22.15M	$15.30M	$22.93M
Total Long-Term Assets	$679.7K	$600.0K	$89.27K
Total Assets	$22.83M	$15.90M	$23.02M
YoY Change	11.92%	-30.87%	15498.15%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$819.9K	$1.400M	$651.9K
YoY Change	116.69%	100.0%	28.97%
Accrued Expenses	$724.5K	$800.0K	$503.1K
YoY Change	91.43%	60.0%	289.33%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$700.0K	$400.0K
YoY Change
Total Short-Term Liabilities	$2.248M	$2.600M	$1.180M
YoY Change	196.98%	116.67%	65.02%
LONG-TERM LIABILITIES
Long-Term Debt	$2.000M	$2.300M	$0.00
YoY Change			-100.0%
Other Long-Term Liabilities		$0.00	$122.6K
YoY Change		-100.0%	33.03%
Total Long-Term Liabilities	$2.000M	$2.300M	$122.6K
YoY Change		2200.0%	33.03%
TOTAL LIABILITIES
Total Short-Term Liabilities	$2.248M	$2.600M	$1.180M
Total Long-Term Liabilities	$2.000M	$2.300M	$122.6K
Total Liabilities	$4.279M	$4.200M	$1.303M
YoY Change	465.37%	320.0%	-21.64%
SHAREHOLDERS EQUITY
Retained Earnings
YoY Change
Common Stock	$1.361K		$961.00
YoY Change	39.59%		137.28%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$19.40M	$11.80M	$21.99M
YoY Change
Total Liabilities & Shareholders Equity	$22.83M	$15.90M	$23.02M
YoY Change	11.92%	-30.87%	15498.15%

Cashflow Statement

Concept	2015 Q1	2014	2013 Q4
OPERATING ACTIVITIES
Net Income	-$3.909M	-$11.79M	-$2.060M
YoY Change	67.73%	29.93%	174.67%
Depreciation, Depletion And Amortization	$25.61K	$66.90K	$10.00K
YoY Change	1080.28%	953.8%
Cash From Operating Activities	-$4.462M	-$9.829M	-$1.620M
YoY Change	86.63%	53.85%	211.54%
INVESTING ACTIVITIES
Capital Expenditures	$8.280K	$458.7K	$40.00K
YoY Change	60.62%	830.02%
Acquisitions
YoY Change
Other Investing Activities	-$110.0K	$6.420M	-$17.35M
YoY Change	-122.92%	-137.0%
Cash From Investing Activities	-$114.2K	$5.966M	-$17.39M
YoY Change	-123.91%	-134.29%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net	$11.10M	$0.00
YoY Change		-100.0%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	$11.13M	$3.010M	10.00K
YoY Change	30204.58%	-89.38%	-97.44%
NET CHANGE
Cash From Operating Activities	-$4.462M	-$9.829M	-1.620M
Cash From Investing Activities	-$114.2K	$5.966M	-17.39M
Cash From Financing Activities	$11.13M	$3.010M	10.00K
Net Change In Cash	$6.553M	-$852.7K	-19.00M
YoY Change	-449.19%	-118.69%	14515.38%
FREE CASH FLOW
Cash From Operating Activities	-$4.462M	-$9.829M	-$1.620M
Capital Expenditures	$8.280K	$458.7K	$40.00K
Free Cash Flow	-$4.471M	-$10.29M	-$1.660M
YoY Change	86.58%	59.8%	219.23%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2014	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	2861231	USD
CY2013	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	2737688	USD
CY2014	htbx	Clinical And Regulatory Expense ClinicalAndRegulatoryExpense	5348091	USD
CY2013	htbx	Clinical And Regulatory Expense ClinicalAndRegulatoryExpense	1397157	USD
CY2014	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	3977605	USD
CY2013	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	2429796	USD
CY2014	us-gaap	Operating Expenses OperatingExpenses	12186927	USD
CY2013	us-gaap	Operating Expenses OperatingExpenses	6564641	USD
CY2014	us-gaap	Operating Income Loss OperatingIncomeLoss	-12186927	USD
CY2013	us-gaap	Operating Income Loss OperatingIncomeLoss	-6564641	USD
CY2014	us-gaap	Interest And Dividend Income Operating InterestAndDividendIncomeOperating	40570	USD
CY2013	us-gaap	Interest And Dividend Income Operating InterestAndDividendIncomeOperating	10068	USD
CY2014	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-23500	USD
CY2013	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	23828	USD
CY2014	us-gaap	Interest Expense InterestExpense	73354	USD
CY2013	us-gaap	Interest Expense InterestExpense	79119	USD
CY2014	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-56284	USD
CY2013	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-45223	USD
CY2014	us-gaap	Profit Loss ProfitLoss	-12243211	USD
CY2013	us-gaap	Profit Loss ProfitLoss	-6609864	USD
CY2014	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-454394	USD
CY2013	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-198516	USD
CY2014	us-gaap	Debt Instrument Convertible Beneficial Conversion Feature DebtInstrumentConvertibleBeneficialConversionFeature		USD
CY2013	us-gaap	Debt Instrument Convertible Beneficial Conversion Feature DebtInstrumentConvertibleBeneficialConversionFeature	-2300000	USD
CY2014	us-gaap	Preferred Stock Dividends Income Statement Impact PreferredStockDividendsIncomeStatementImpact		USD
CY2013	us-gaap	Preferred Stock Dividends Income Statement Impact PreferredStockDividendsIncomeStatementImpact	361668	USD
CY2014	us-gaap	Net Income Loss NetIncomeLoss	-11788817	USD
CY2013	us-gaap	Net Income Loss NetIncomeLoss	-9073016	USD
CY2014	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-1.83
CY2013	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-2.42
CY2014	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	6454866	shares
CY2013	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	3747357	shares
CY2012Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-1515109	USD
CY2013	htbx	Preferred Stock Issued During Period Value Issued For Cash PreferredStockIssuedDuringPeriodValueIssuedForCash	5050090	USD
CY2013	htbx	Stock Issued During Period Value Conversion Of Shares Transaction One StockIssuedDuringPeriodValueConversionOfSharesTransactionOne		USD
CY2013	htbx	Stock Issued During Period Value Conversion Of Shares Transaction Two StockIssuedDuringPeriodValueConversionOfSharesTransactionTwo		USD
CY2013	htbx	Stock Issued During Period Value Conversion Of Shares Transaction Three StockIssuedDuringPeriodValueConversionOfSharesTransactionThree		USD
CY2013	us-gaap	Stock Issued During Period Value Issued For Cash StockIssuedDuringPeriodValueIssuedForCash	25110540	USD
CY2013	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	54042	USD
CY2013	us-gaap	Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures		USD
CY2013	us-gaap	Stock Issued During Period Value Stock Dividend StockIssuedDuringPeriodValueStockDividend		USD
CY2013	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	571924	USD
CY2013	us-gaap	Adjustments To Additional Paid In Capital Stock Issued Issuance Costs AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts	-944478	USD
CY2013Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	21717145	USD
CY2014	us-gaap	Increase Decrease In Interest Payable Net IncreaseDecreaseInInterestPayableNet	-25364	USD
CY2013	us-gaap	Increase Decrease In Interest Payable Net IncreaseDecreaseInInterestPayableNet	11601	USD
CY2014	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	37936	USD
CY2014	htbx	Cashless Exercise Of Stock Option CashlessExerciseOfStockOption		USD
CY2014	us-gaap	Adjustments To Additional Paid In Capital Warrant Issued AdjustmentsToAdditionalPaidInCapitalWarrantIssued	452874	USD
CY2014	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	1066443	USD
CY2014Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	11031187	USD
CY2014	us-gaap	Income Loss Including Portion Attributable To Noncontrolling Interest IncomeLossIncludingPortionAttributableToNoncontrollingInterest	-12243211	USD
CY2013	us-gaap	Income Loss Including Portion Attributable To Noncontrolling Interest IncomeLossIncludingPortionAttributableToNoncontrollingInterest	-6609864	USD
CY2014	us-gaap	Depreciation Depreciation	66895	USD
CY2013	us-gaap	Depreciation Depreciation	6348	USD
CY2014	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	37556	USD
CY2013	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	28229	USD
CY2014	htbx	Amortization On Bond Premium AmortizationOnBondPremium	173204	USD
CY2013	htbx	Amortization On Bond Premium AmortizationOnBondPremium	50781	USD
CY2014	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	7263	USD
CY2013	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	30440	USD
CY2014	us-gaap	Share Based Compensation ShareBasedCompensation	1066443	USD
CY2013	us-gaap	Share Based Compensation ShareBasedCompensation	571924	USD
CY2014	us-gaap	Increase Decrease In Due From Related Parties Current IncreaseDecreaseInDueFromRelatedPartiesCurrent	23696	USD
CY2013	us-gaap	Increase Decrease In Due From Related Parties Current IncreaseDecreaseInDueFromRelatedPartiesCurrent	15375	USD
CY2014	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-203411	USD
CY2013	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	1008202	USD
CY2014	us-gaap	Increase Decrease In Restricted Cash IncreaseDecreaseInRestrictedCash	99877	USD
CY2013	us-gaap	Increase Decrease In Restricted Cash IncreaseDecreaseInRestrictedCash	-24962	USD
CY2014	us-gaap	Increase Decrease In Deposits IncreaseDecreaseInDeposits	-10478	USD
CY2013	us-gaap	Increase Decrease In Deposits IncreaseDecreaseInDeposits		USD
CY2014	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	715509	USD
CY2013	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	146446	USD
CY2014	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	302918	USD
CY2013	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	373842	USD
CY2014	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-9829427	USD
CY2013	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-6388868	USD
CY2014	us-gaap	Proceeds From Sale Maturity And Collection Of Shortterm Investments ProceedsFromSaleMaturityAndCollectionOfShorttermInvestments	18623826	USD
CY2013	us-gaap	Proceeds From Sale Maturity And Collection Of Shortterm Investments ProceedsFromSaleMaturityAndCollectionOfShorttermInvestments		USD
CY2014	us-gaap	Payments To Acquire Short Term Investments PaymentsToAcquireShortTermInvestments	12198847	USD
CY2013	us-gaap	Payments To Acquire Short Term Investments PaymentsToAcquireShortTermInvestments	17347946	USD
CY2014	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	458676	USD
CY2013	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	49319	USD
CY2014	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	5966303	USD
CY2013	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-17397265	USD
CY2014	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	2972500	USD
CY2013	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt		USD
CY2014	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable		USD
CY2013	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	200000	USD
CY2014	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable		USD
CY2014	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt		USD
CY2013	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	-197099	USD
CY2014	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock		USD
CY2013	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	540	USD
CY2014	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	37936	USD
CY2013	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	54042	USD
CY2014	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts		USD
CY2013	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	944478	USD
CY2014	us-gaap	Interest Paid InterestPaid	32025	USD
CY2013	us-gaap	Interest Paid InterestPaid	60922	USD
CY2014	htbx	Non Cash Conversion Of Preferred Stock Into Common Stock NonCashConversionOfPreferredStockIntoCommonStock		USD
CY2014	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	3010436	USD
CY2013	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	28348095	USD
CY2014	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	-852688	USD
CY2013	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	4561962	USD
CY2012Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	5030	USD
CY2014Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	3714304	USD
CY2013Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	4566992	USD
CY2013	htbx	Non Cash Conversion Of Preferred Stock Into Common Stock NonCashConversionOfPreferredStockIntoCommonStock	386	USD
CY2014	us-gaap	Dividends Preferred Stock DividendsPreferredStock		USD
CY2013	us-gaap	Dividends Preferred Stock DividendsPreferredStock	361668	USD
CY2014	htbx	Cashless Exercise Of Stock Warrants CashlessExerciseOfStockWarrants	452874	USD
CY2013	htbx	Cashless Exercise Of Stock Warrants CashlessExerciseOfStockWarrants		USD
CY2014	htbx	Noncash Investing And Financing Items Warrants Issued NoncashInvestingAndFinancingItemsWarrantsIssued	323021	USD
CY2013	htbx	Noncash Investing And Financing Items Warrants Issued NoncashInvestingAndFinancingItemsWarrantsIssued		USD
CY2014	dei	Entity Registrant Name EntityRegistrantName	HEAT BIOLOGICS, INC.
CY2014	dei	Entity Central Index Key EntityCentralIndexKey	0001476963
CY2014	dei	Document Type DocumentType	10-K
CY2014	dei	Document Period End Date DocumentPeriodEndDate	2014-12-31
CY2014	dei	Amendment Flag AmendmentFlag	false
CY2014	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2014	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2014	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2014	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2014	dei	Entity Filer Category EntityFilerCategory	Smaller Reporting Company
CY2014	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2014
CY2014	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2014Q2	dei	Entity Public Float EntityPublicFloat	24626449	USD
CY2015Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	8394456	shares
CY2014Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	521988	USD
CY2013Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	63312	USD
CY2014Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	76454	USD
CY2013Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	9559	USD
CY2014Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	445534	USD
CY2013Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	53753	USD
CY2014	us-gaap	Stockholders Equity Note Stock Split Conversion Ratio1 StockholdersEquityNoteStockSplitConversionRatio1	0.4348	pure
CY2014Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Next Twelve Months LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths	397465	USD
CY2014Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Two LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo	1223502	USD
CY2014Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Three LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree	1223502	USD
CY2014Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Four LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour	155531	USD
CY2014Q4	us-gaap	Long Term Debt LongTermDebt	3000000	USD
CY2011Q4	us-gaap	Debt Instrument Face Amount DebtInstrumentFaceAmount	950000	USD
CY2011Q4	us-gaap	Debt Instrument Interest Rate Stated Percentage DebtInstrumentInterestRateStatedPercentage	0.12	pure
CY2013Q2	us-gaap	Stockholders Equity Reverse Stock Split StockholdersEquityReverseStockSplit	0.4348
CY2013Q3	us-gaap	Repayments Of Convertible Debt RepaymentsOfConvertibleDebt	197099	USD
CY2011Q4	us-gaap	Debt Conversion Description DebtConversionDescription	<div id='EdgarSAA123457890000' style="font-family : 'Times New Roman';">The note is convertible into common or Series A preferred stock at the latest valuation. The type of security converted will depend on whether common or Series A preferred stock is issued as part of a successful future equity raise of at least $7.5 million at the qualified offering price.</div>
CY2011Q4	us-gaap	Debt Instrument Maturity Date DebtInstrumentMaturityDate	2019-10-31
CY2014Q4	us-gaap	Held To Maturity Securities Current HeldToMaturitySecuritiesCurrent	10698982	USD
CY2013Q4	us-gaap	Held To Maturity Securities Current HeldToMaturitySecuritiesCurrent	17297165	USD
CY2014Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	863227	USD
CY2013Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	1066638	USD
CY2014Q4	us-gaap	Assets Current AssetsCurrent	15276513	USD
CY2013Q4	us-gaap	Assets Current AssetsCurrent	22930795	USD
CY2014Q4	us-gaap	Restricted Cash And Cash Equivalents Noncurrent RestrictedCashAndCashEquivalentsNoncurrent	101129	USD
CY2013Q4	us-gaap	Restricted Cash And Cash Equivalents Noncurrent RestrictedCashAndCashEquivalentsNoncurrent	1252	USD
CY2014Q4	us-gaap	Deposits Assets Noncurrent DepositsAssetsNoncurrent	19798	USD
CY2013Q4	us-gaap	Deposits Assets Noncurrent DepositsAssetsNoncurrent	9320	USD
CY2014Q4	us-gaap	Deferred Finance Costs Noncurrent Net DeferredFinanceCostsNoncurrentNet	24554	USD
CY2013Q4	us-gaap	Deferred Finance Costs Noncurrent Net DeferredFinanceCostsNoncurrentNet		USD
CY2014Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	194123	USD
CY2013Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	35518	USD
CY2014Q4	us-gaap	Assets Assets	15916170	USD
CY2013Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2013Q4	us-gaap	Assets Assets	23020066	USD
CY2014Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	1367426	USD
CY2013Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	651917	USD
CY2014Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	805968	USD
CY2013Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	503050	USD
CY2014Q4	us-gaap	Interest Payable Current InterestPayableCurrent		USD
CY2013Q4	us-gaap	Interest Payable Current InterestPayableCurrent	25364	USD
CY2014Q4	us-gaap	Liabilities Current LiabilitiesCurrent	2570859	USD
CY2013Q4	us-gaap	Liabilities Current LiabilitiesCurrent	1180331	USD
CY2014Q4	us-gaap	Long Term Notes Payable LongTermNotesPayable	2314124	USD
CY2014Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	6492622	shares
CY2013Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	50000000	shares
CY2013Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0002
CY2014Q4	us-gaap	Due From Related Parties Noncurrent DueFromRelatedPartiesNoncurrent	48642	USD
CY2013Q4	us-gaap	Due From Related Parties Noncurrent DueFromRelatedPartiesNoncurrent	24946	USD
CY2014Q4	us-gaap	Notes Payable Current NotesPayableCurrent	397465	USD
CY2013Q4	us-gaap	Notes Payable Current NotesPayableCurrent		USD
CY2014Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2013Q4	us-gaap	Long Term Notes Payable LongTermNotesPayable		USD
CY2014Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent		USD
CY2013Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	122590	USD
CY2014Q4	us-gaap	Liabilities Liabilities	4884983	USD
CY2013Q4	us-gaap	Liabilities Liabilities	1302921	USD
CY2014Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0002
CY2014Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	50000000	shares
CY2014Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	6492622	shares
CY2013Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	6375426	shares
CY2014Q4	us-gaap	Common Stock Value CommonStockValue	982	USD
CY2013Q4	us-gaap	Common Stock Value CommonStockValue	961	USD
CY2014Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	35894823	USD
CY2013Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	34337591	USD
CY2014Q4	us-gaap	Development Stage Enterprise Deficit Accumulated During Development Stage DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage	24135447	USD
CY2013Q4	us-gaap	Development Stage Enterprise Deficit Accumulated During Development Stage DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage	12346630	USD
CY2014Q4	us-gaap	Stockholders Equity StockholdersEquity	11760358	USD
CY2013Q4	us-gaap	Stockholders Equity StockholdersEquity	21991922	USD
CY2014Q4	us-gaap	Minority Interest MinorityInterest	-729171	USD
CY2013Q4	us-gaap	Minority Interest MinorityInterest	-274777	USD
CY2014Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	15916170	USD
CY2013Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	23020066	USD
CY2013Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	6375426	shares
CY2014Q4	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	101129	USD
CY2013Q4	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	1252	USD
CY2014Q4	htbx	Minimum Cash Balance To Pay Trademark Fees MinimumCashBalanceToPayTrademarkFees	1000	USD
CY2014Q4	htbx	Minimum Cash Balance With Lending Bank MinimumCashBalanceWithLendingBank	100000	USD
CY2014Q4	us-gaap	Cash Fdic Insured Amount CashFDICInsuredAmount	250000	USD
CY2014Q4	us-gaap	Cash Uninsured Amount CashUninsuredAmount	3704026	USD
CY2014	htbx	Capitalized Costs Property And Equipment CapitalizedCostsPropertyAndEquipment	500	USD
CY2014	us-gaap	Use Of Estimates UseOfEstimates	<div id='EdgarSAA123457890000' style="font-family : 'Times New Roman';"> <p style="margin: 0px; font-family: 'times new roman';"><font style="font-size: 10pt;"><b><i>Use of Estimates</i></b></font></p> <p style="margin: 0px; font-family: 'times new roman';" align="justify"><br/></p> <p style="margin: 0px; font-family: 'times new roman';"><font style="font-size: 10pt;">The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. Estimates are used for, but not limited to, useful lives of fixed assets, income taxes and stock-based compensation. Actual results may differ from those estimates.</font></p> <p style="margin: 0px; font-family: 'times new roman';" align="justify"><br/></p> </div>
CY2014Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	40000	USD
CY2013Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	40000	USD
CY2014Q4	us-gaap	Accrued Rent Current AccruedRentCurrent	51155	USD
CY2013Q4	us-gaap	Accrued Rent Current AccruedRentCurrent		USD
CY2014Q4	htbx	Accrued Clinical Trial Expense Current AccruedClinicalTrialExpenseCurrent	195721	USD
CY2013Q4	htbx	Accrued Clinical Trial Expense Current AccruedClinicalTrialExpenseCurrent	106462	USD
CY2014	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<div id='EdgarSAA123457890000' style="font-family : 'Times New Roman';"> <p style="margin: 0px; font-family: 'times new roman';"><font style="font-size: 10pt;"><b><i>Concentration of Credit Risk</i></b></font></p> <p style="margin: 0px; font-family: 'times new roman';"><br/></p> <p style="margin: 0px; font-family: 'times new roman';"><font style="font-size: 10pt;">At times, cash balances may exceed the Federal Deposit Insurance Corporation (FDIC) insurable limits. The Company has never experienced any losses related to these balances. As of December 31, 2014 and 2013, cash amounts in excess of $<font>250,000</font> were not fully insured. The uninsured cash balance as of December 31, 2014 was $<font>3,704,026</font>. The Company does not believe it is exposed to significant credit risk on cash and cash equivalents.</font></p> <p style="margin: 0px; font-family: 'times new roman';"><br/></p> </div>
CY2011Q4	htbx	Unpaid License Fees UnpaidLicenseFees	160000	USD
CY2014Q4	us-gaap	Debt Instrument Interest Rate Effective Percentage DebtInstrumentInterestRateEffectivePercentage	0.18	pure
CY2013Q4	us-gaap	Cash Fdic Insured Amount CashFDICInsuredAmount	250000	USD
CY2014Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	519092	USD
CY2013Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	356588	USD
CY2009Q2	htbx	Additional Consideration AdditionalConsideration	12500	USD
CY2009Q2	htbx	Future Minimum Royalty Payments Three Years Amount FutureMinimumRoyaltyPaymentsThreeYearsAmount	10000	USD
CY2009Q2	htbx	Future Minimum Royalty Payments Remainder Life Of Agreement FutureMinimumRoyaltyPaymentsRemainderLifeOfAgreement	20000	USD
CY2017Q2	htbx	Milestone Payment MilestonePayment	250000	USD
CY2010Q3	htbx	Option Fees OptionFees	2000	USD
CY2011Q3	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	10000	USD
CY2014Q4	htbx	Future Minimum Royalty Payments Due Current FutureMinimumRoyaltyPaymentsDueCurrent	33000	USD
CY2014Q4	htbx	Future Minimum Royalty Payments Due In Two Years FutureMinimumRoyaltyPaymentsDueInTwoYears	33000	USD
CY2014Q4	htbx	Future Minimum Royalty Payments Due In Three Years FutureMinimumRoyaltyPaymentsDueInThreeYears	283000	USD
CY2014Q4	htbx	Future Minimum Royalty Payments Due In Four Years FutureMinimumRoyaltyPaymentsDueInFourYears	33000	USD
CY2014Q4	htbx	Future Minimum Royalty Payments Due In Five Years FutureMinimumRoyaltyPaymentsDueInFiveYears	33000	USD
CY2014Q4	htbx	Future Minimum Royalty Payments Due Thereafter FutureMinimumRoyaltyPaymentsDueThereafter	99000	USD
CY2014Q4	htbx	Future Minimum Royalty Payments Due FutureMinimumRoyaltyPaymentsDue	514000	USD
CY2014Q1	us-gaap	Lessee Leasing Arrangements Operating Leases Term Of Contract LesseeLeasingArrangementsOperatingLeasesTermOfContract	P5Y
CY2014Q1	htbx	Monthly Rental Payments MonthlyRentalPayments	10341	USD
CY2014Q3	htbx	Monthly Rental Payments MonthlyRentalPayments	11638	USD
CY2013	htbx	Monthly Rental Payments MonthlyRentalPayments	4046	USD
CY2014	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	100973	USD
CY2013	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	48377	USD
CY2014Q4	us-gaap	Operating Leases Future Minimum Payments Due Current OperatingLeasesFutureMinimumPaymentsDueCurrent	192833	USD
CY2014Q4	us-gaap	Operating Leases Future Minimum Payments Due In Two Years OperatingLeasesFutureMinimumPaymentsDueInTwoYears	218271	USD
CY2014Q4	us-gaap	Operating Leases Future Minimum Payments Due In Three Years OperatingLeasesFutureMinimumPaymentsDueInThreeYears	224282	USD
CY2014Q4	us-gaap	Operating Leases Future Minimum Payments Due In Four Years OperatingLeasesFutureMinimumPaymentsDueInFourYears	231010	USD
CY2014Q4	us-gaap	Operating Leases Future Minimum Payments Due In Five Years OperatingLeasesFutureMinimumPaymentsDueInFiveYears	194401	USD
CY2014Q4	us-gaap	Operating Leases Future Minimum Payments Due OperatingLeasesFutureMinimumPaymentsDue	1060797	USD
CY2014	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Issues FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues	323021	USD
CY2014	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings	7263	USD
CY2014Q4	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue		USD
CY2014	us-gaap	Common Stock Dividends Shares CommonStockDividendsShares	36167	shares
CY2014	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0.000	pure
CY2013	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0.000	pure
CY2013	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	186736	shares
CY2013	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	10.07
CY2013	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	80706	shares
CY2013	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	0.67
CY2013	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	62595	shares
CY2013	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	1.96
CY2014Q4	us-gaap	Due To Related Parties Current DueToRelatedPartiesCurrent	26750	USD
CY2013Q4	us-gaap	Due To Related Parties Current DueToRelatedPartiesCurrent	13000	USD
CY2013Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	4840490	USD
CY2012Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	590047	shares
CY2012Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	0.71
CY2014	us-gaap	Advertising Cost Policy Expensed Advertising Cost AdvertisingCostPolicyExpensedAdvertisingCost	<div id='EdgarSAA123457890000' style="font-family : 'Times New Roman';"> <p style="margin: 0px; font-family: 'times new roman';" align="justify"><font style="font-size: 10pt;"><b><i>Marketing</i></b></font></p> <p style="margin: 0px; font-family: 'times new roman';" align="justify"><br/></p> <p style="margin: 0px; font-family: 'times new roman';"><font style="font-size: 10pt;">Marketing costs are expensed as incurred. Marketing expense totaled $<font>135,372</font> and $<font>135,366</font> for the years ended December 31, 2014 and 2013, respectively.</font></p> </div>
CY2013Q4	htbx	Common Stock Fair Value Per Share CommonStockFairValuePerShare	8.81
CY2013Q4	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue	122590	USD
CY2013	us-gaap	Income Tax Reconciliation Change In Enacted Tax Rate IncomeTaxReconciliationChangeInEnactedTaxRate	32774	USD
CY2014	us-gaap	Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost	135008	USD
CY2013	us-gaap	Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost		USD
CY2013Q3	htbx	Proceeds From Issuance Initial Public Offering Gross ProceedsFromIssuanceInitialPublicOfferingGross	1000000	USD
CY2013Q3	htbx	Proceeds From Issuance Initial Public Offering Net ProceedsFromIssuanceInitialPublicOfferingNet	930000	USD
CY2013Q4	htbx	Effective Conversion Price Per Share EffectiveConversionPricePerShare	6.14
CY2014	us-gaap	Marketing Expense MarketingExpense	135372	USD
CY2013	us-gaap	Marketing Expense MarketingExpense	135366	USD
CY2012Q4	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue	92150	USD
CY2013	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings	30440	USD
CY2014	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	4747766	USD
CY2013	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	2414695	USD
CY2014Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	8141857	USD
CY2013Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	4167785	USD
CY2014Q4	us-gaap	Deferred Tax Assets In Process Research And Development DeferredTaxAssetsInProcessResearchAndDevelopment	961445	USD
CY2013Q4	us-gaap	Deferred Tax Assets In Process Research And Development DeferredTaxAssetsInProcessResearchAndDevelopment	424739	USD
CY2014Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	484954	USD
CY2013Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	247966	USD
CY2014Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	9588256	USD
CY2014	us-gaap	Income Tax Reconciliation Nondeductible Expense IncomeTaxReconciliationNondeductibleExpense	239213	USD
CY2013Q3	us-gaap	Stock Issued During Period Shares Issued For Cash StockIssuedDuringPeriodSharesIssuedForCash	100000	shares
CY2013Q3	us-gaap	Equity Issuance Per Share Amount EquityIssuancePerShareAmount	10.00
CY2013Q3	htbx	Proceeds From Issuance Initial Public Offering Gross ProceedsFromIssuanceInitialPublicOfferingGross	1000000	USD
CY2013Q3	htbx	Proceeds From Issuance Initial Public Offering Net ProceedsFromIssuanceInitialPublicOfferingNet	930000	USD
CY2014	htbx	Proceeds From Issuance Initial Public Offering Gross ProceedsFromIssuanceInitialPublicOfferingGross	27000000	USD
CY2014	htbx	Proceeds From Issuance Initial Public Offering Net ProceedsFromIssuanceInitialPublicOfferingNet	24300000	USD
CY2014	us-gaap	Conversion Of Stock Shares Issued1 ConversionOfStockSharesIssued1	1696683	shares
CY2014	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit		USD
CY2013	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit		USD
CY2014	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit		USD
CY2013	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit		USD
CY2014	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit		USD
CY2013	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit		USD
CY2014	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit		USD
CY2013	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit		USD
CY2014	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		USD
CY2013	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		USD
CY2014	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.34	pure
CY2014	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-4162691	USD
CY2013	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-2247353	USD
CY2014	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	-344247	USD
CY2013	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	-186475	USD
CY2013	us-gaap	Income Tax Reconciliation Nondeductible Expense IncomeTaxReconciliationNondeductibleExpense	4985	USD
CY2014	us-gaap	Income Tax Reconciliation Prior Year Income Taxes IncomeTaxReconciliationPriorYearIncomeTaxes	-161018	USD
CY2013	us-gaap	Income Tax Reconciliation Prior Year Income Taxes IncomeTaxReconciliationPriorYearIncomeTaxes	162061	USD
CY2014	us-gaap	Income Tax Reconciliation Nondeductible Expense Research And Development IncomeTaxReconciliationNondeductibleExpenseResearchAndDevelopment	-454031	USD
CY2013	us-gaap	Income Tax Reconciliation Nondeductible Expense Research And Development IncomeTaxReconciliationNondeductibleExpenseResearchAndDevelopment	-180687	USD
CY2014	us-gaap	Income Tax Reconciliation Change In Enacted Tax Rate IncomeTaxReconciliationChangeInEnactedTaxRate		USD
CY2014Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet		USD
CY2013Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet		USD
CY2014	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	4747766	USD
CY2014Q4	us-gaap	Operating Loss Carryforwards OperatingLossCarryforwards	42039675	USD
CY2014Q4	htbx	Preferred Stock Redemption Public Offering Net Proceeds Threshold PreferredStockRedemptionPublicOfferingNetProceedsThreshold	15000000	USD
CY2014Q4	us-gaap	Convertible Preferred Stock Shares Issued Upon Conversion ConvertiblePreferredStockSharesIssuedUponConversion	0.4348	shares
CY2013Q3	us-gaap	Stock Issued During Period Shares Issued For Cash StockIssuedDuringPeriodSharesIssuedForCash	2500000	shares
CY2013Q3	us-gaap	Equity Issuance Per Share Amount EquityIssuancePerShareAmount	10.00
CY2013Q3	htbx	Proceeds From Issuance Initial Public Offering Gross ProceedsFromIssuanceInitialPublicOfferingGross	25000000	USD
CY2013Q3	htbx	Proceeds From Issuance Initial Public Offering Net ProceedsFromIssuanceInitialPublicOfferingNet	22400000	USD
CY2013Q3	us-gaap	Stock Issued During Period Shares Issued For Cash StockIssuedDuringPeriodSharesIssuedForCash	100000	shares
CY2013Q3	us-gaap	Equity Issuance Per Share Amount EquityIssuancePerShareAmount	10.00
CY2013Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	633482	shares
CY2013Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	3.36
CY2014	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	507879	shares
CY2014	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	6.30
CY2014	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	78664	shares
CY2014	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	0.60
CY2014	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	44107	shares
CY2014	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	3.19
CY2014Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	1018590	shares
CY2014Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	5.04
CY2014	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	5.66
CY2013	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	8.51
CY2014	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1	1704121	USD
CY2014Q4	us-gaap	Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Outstanding Options ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions	1018590	shares
CY2014	us-gaap	Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Remaining Contractual Term2 SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2	P7Y9M22D
CY2014Q4	us-gaap	Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Exercise Price Beginning Balance1 SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1	5.04
CY2014Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	473696	shares
CY2014	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P5Y11M26D
CY2014Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	2.67
CY2014Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber	473696	shares
CY2014	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1	P5Y11M26D
CY2014Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice	2.67
CY2014Q4	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions	3872221	USD
CY2014	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1 EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1	P14M27D

Files In Submission

Name	View Source	Status
0001553350-15-000277-index-headers.html	Edgar Link	pending
0001553350-15-000277-index.html	Edgar Link	pending
0001553350-15-000277.txt	Edgar Link	pending
0001553350-15-000277-xbrl.zip	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xls	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
htbx-20141231.xml	Edgar Link	completed
htbx-20141231.xsd	Edgar Link	pending
htbx-20141231_cal.xml	Edgar Link	unprocessable
htbx-20141231_def.xml	Edgar Link	unprocessable
htbx-20141231_lab.xml	Edgar Link	unprocessable
htbx-20141231_pre.xml	Edgar Link	unprocessable
htbx_10k.htm	Edgar Link	pending
htbx_10k002.gif	Edgar Link	pending
htbx_10k004.gif	Edgar Link	pending
htbx_10k006.gif	Edgar Link	pending
htbx_10k007.jpg	Edgar Link	pending
htbx_10k008.jpg	Edgar Link	pending
htbx_ex10z39.htm	Edgar Link	pending
htbx_ex10z39003.gif	Edgar Link	pending
htbx_ex10z39004.gif	Edgar Link	pending
htbx_ex10z39005.jpg	Edgar Link	pending
htbx_ex10z39006.jpg	Edgar Link	pending
htbx_ex10z39007.jpg	Edgar Link	pending
htbx_ex10z39008.jpg	Edgar Link	pending
htbx_ex10z47.htm	Edgar Link	pending
htbx_ex10z47001.jpg	Edgar Link	pending
htbx_ex10z47002.jpg	Edgar Link	pending
htbx_ex10z48.htm	Edgar Link	pending
htbx_ex10z48001.jpg	Edgar Link	pending
htbx_ex10z48002.jpg	Edgar Link	pending
htbx_ex10z48004.gif	Edgar Link	pending
htbx_ex21z1.htm	Edgar Link	pending
htbx_ex23z1.htm	Edgar Link	pending
htbx_ex31z1.htm	Edgar Link	pending
htbx_ex31z2.htm	Edgar Link	pending
htbx_ex32z1.htm	Edgar Link	pending
htbx_ex32z2.htm	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$SCPX
Scorpius Holdings, Inc. Stock $scpx

2015 Q1 Form 10-K Financial Statement

#000155335015000277 Filed on March 27, 2015

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$SCPX Scorpius Holdings, Inc. Stock $scpx

2015 Q1 Form 10-K Financial Statement

#000155335015000277 Filed on March 27, 2015

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$SCPX
Scorpius Holdings, Inc. Stock $scpx